The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1-thymopentin fusion peptide and its binding to TLR2.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cancer Letters

• Publication date

  2013-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.canlet.2013.05.006PMID 23684552
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis.

  2013cited by this paper
• Intein-mediated expression, purification, and characterization of thymosin α1-thymopentin fusion peptide in Escherichia coli.

  2012cited by this paper
• TLR1/TLR2 Agonist Induces Tumor Regression by Reciprocal Modulation of Effector and Regulatory T Cells

  2011cited by this paper
• Bioactivity and pharmacokinetics of two human serum albumin–thymosin α1-fusion proteins, rHSA-Tα1 and rHSA-L-Tα1, expressed in recombinant Pichia pastoris

  2010cited by this paper
• Potential Role of Thymosin-α1 Adjuvant Therapy for Glioblastoma

  2010cited by this paper
• Novel thymopentin release systems prepared from bioresorbable PLA-PEG-PLA hydrogels.

  2010cited by this paper
• Binding and Cellular Activation Studies Reveal That Toll-like Receptor 2 Can Differentially Recognize Peptidoglycan from Gram-positive and Gram-negative Bacteria*

  2009cited by this paper
• Antitumor effects and immunoregulation mechanisms of IL-23 gene in mouse mammary cancer mediated by retrovirus.

  2009cited by this paper
• Reviews for APASL guidelines: immunomodulator therapy of chronic hepatitis B

  2008cited by this paper
• Efficacy of triple therapy with thymalfasin, peginterferon alpha-2a, and ribavirin for the treatment of hispanic chronic HCV nonresponders.

  2008cited by this paper
• Expression of thymosin α1-thymopentin fusion peptide in Pichia pastoris and its characterization

  2008cited by this paper
• Combination therapy of thymosin alpha‐1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study

  2008cited by this paper
• Thymosin α1 as a Chemopreventive Agent in Lung and Breast Cancer

  2007cited by this paper
• Signaling Pathways Leading to the Activation of IKK and MAPK by Thymosin α1

  2007cited by this paper
• Thymosin alpha1 as a chemopreventive agent in lung and breast cancer.

  2007cited by this paper
• MHC class I antigens and immune surveillance in transformed cells.

  2007cited by this paper
• Signaling pathways leading to the activation of IKK and MAPK by thymosin alpha1.

  2007cited by this paper
• Colon cancer and the immune system: the role of tumor invading T cells.

  2006cited by this paper
• Cytotoxic T cells.

  2006cited by this paper
• Pretreatment with neem (Azadirachta indica) leaf preparation in swiss mice diminishes leukopenia and enhances the antitumor activity of cyclophosphamide

  2006cited by this paper
• Synergistic Effect Between Ouabain and Glucocorticoids for the Induction of Thymic Atrophy

  2006cited by this paper
• TLR2 is expressed on activated T cells as a costimulatory receptor.

  2004cited by this paper
• Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling.

  2004cited by this paper
• Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer.

  2003cited by this paper
• Thymosin α1 in combination with cytokines and chemotherapy for the treatment of cancer

  2003cited by this paper
• Thymosin alpha1 inhibits mammary carcinogenesis in Fisher rats.

  2002cited by this paper
• Involvement of mitogen-activated protein kinases in the signal transduction pathway of bone marrow-derived macrophage activation in response to in vitro treatment with thymosin alpha 1.

  2002cited by this paper
• Thymosin α1 inhibits mammary carcinogenesis in Fisher rats

  2002cited by this paper
• Characterization of the Major Histocompatibility Complex Class I Deficiencies in B 16 Melanoma Cells 1

  2001cited by this paper
• Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells.

  2001cited by this paper
• Thymosin alpha1 is a time and dose-dependent antagonist of dexamethasone-induced apoptosis of murine thymocytes in vitro.

  2000cited by this paper
• Thymosin α1 application augments immune response and down-regulates tumor weight and organ colonization in BALB/c-mice

  2000cited by this paper
• Thymosin alpha(1) application augments immune response and down-regulates tumor weight and organ colonization in BALB/c-mice.

  2000cited by this paper
• Thymosin‐α1 regulates MHC class I expression in FRTL‐5 cells at transcriptional level

  2000cited by this paper
• A NF-kappa B/c-myc-dependent survival pathway is targeted by corticosteroids in immature thymocytes.

  1999cited by this paper
• Thymopentin and splenopentin as immunomodulators

  1998cited by this paper
• Evaluation of clinical efficacy and tolerability of intravenous high dose thymopentin in advanced melanoma patients

  1998cited by this paper
• Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting IL-12 production.

  1998cited by this paper
• Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes.

  1997cited by this paper
• Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors.

  1997cited by this paper
• Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors.

  1997cited by this paper
• Influence of immunosuppression on the pharmacokinetics and pharmacodynamics of azithromycin in infected mouse tissues.

  1996cited by this paper
• Anti‐tumor effect of combined treatment with thymosin alpha 1 and interleukin‐2 after 5‐fluorouracil in liver metastases from colorectal cancer in rats

  1994cited by this paper
• The structure and mechanism of formation of human calcitonin fibrils.

  1993cited by this paper
• Combination therapy with thymosin alpha 1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice.

  1992cited by this paper
• Combination therapy with thymosin α1 potentiates the anti‐tumor activity of interleukin‐2 with cyclophosphamide in the treatment of the lewis lung carcinoma in mice

  1992cited by this paper
• Interleukin 2 Receptor Expression in Patients With Head and Neck Squamous Carcinoma: Effects of Thymosin α1 In Vitro

  1989cited by this paper
• Interleukin 2 receptor expression in patients with head and neck squamous carcinoma. Effects of thymosin alpha 1 in vitro.

  1989cited by this paper
• Receptors for thymosin alpha 1 on mouse thymocytes.

  1985cited by this paper

• Self‐assembled Palmitic Acid‐modified Thymopentin Functions as a Delivery System of Nanovaccine for Cancer Immunotherapy

  2025cites this paper
• Efficacy and Safety of PRaG Therapy in Elderly Patients with Advanced Malignant Tumors: A Prospective, Multicenter Clinical Study Protocol (PRaG 9.0 Study)

  2025cites this paper
• Progress in peptide and protein therapeutics: Challenges and strategies

  2025cites this paper
• Direct interaction between Lactiplantibacillus plantarum ZJ316-derived lipoteichoic acid and TLR2 mediates anti-inflammatory and barrier-protective effects in intestinal cells.

  2025cites this paper
• Immunomodulatory effect of a polyherbal formulation (Febrojith) on CD4+/CD8+ T cells and associated inflammatory cytokines in experimental animal model

  2025cites this paper
• Modulating effects of heat-killed and live Limosilactobacillus reuteri PSC102 on the immune response and gut microbiota of cyclophosphamide-treated rats

  2024cites this paper
• Molecular hybridization modification improves the stability and immunomodulatory activity of TP5 peptide

  2024cites this paper
• Thymosin α1 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy

  2024cites this paper
• Immuno-Enhancing Effects of Galium aparine L. in Cyclophosphamide-Induced Immunosuppressed Animal Models

  2024cites this paper
• Thymopentin (TP-5) prevents lipopolysaccharide-induced neuroinflammation and dopaminergic neuron injury by inhibiting the NF-κB/NLRP3 signaling pathway.

  2023cites this paper
• The Protective Effects of Water-Soluble Alginic Acid on the N-Terminal of Thymopentin

  2023cites this paper
• Pharmacological characterization of FC-12738: A Novel Retro-Inverso Pentapeptide for Treating Neuroinflammation

  2023influential citation
• Heat-killed Limosilactobacillus reuteri PSC102 Ameliorates Impaired Immunity in Cyclophosphamide-induced Immunosuppressed Mice

  2022cites this paper
• Selection of an Inactivated Enterococcus faecium and Evaluation of its Potential as an Immunomodulator via Intravenous Injection

  2022cites this paper
• Combination of Gemcitabine and Thymosin alpha 1 exhibit a better anti-tumor effect on nasal natural killer/T-cell lymphoma.

  2021cites this paper
• The effectiveness and safety of lienal polypeptide combined with chemotherapy or chemoradiotherapy for non-small cell lung cancer patients in real world

  2021cites this paper
• Design and Immunological Evaluation of a Hybrid Peptide as a Potent TLR2 Agonist by Structure-Based Virtual Screening

  2021cites this paper
• Targeting the TLR2 Receptor With a Novel Thymopentin-Derived Peptide Modulates Immune Responses

  2021influential citation
• Thymopentin alleviates premature ovarian failure in mice by activating YY2/Lin28A and inhibiting the expression of let‐7 family microRNAs

  2021cites this paper
• Thymopentin treatment of murine premature ovarian failure via attenuation of immune cell activity and promotion of the BMP4/Smad9 signalling pathway

  2021influential citation
• Preformulation studies of thymopentin: analytical method development, physicochemical properties, kinetic degradation investigations and formulation perspective

  2021cites this paper
• Fusion of thymosin alpha 1 with mutant IgG1 CH3 prolongs half-life and enhances antitumor effects in vivo.

  2019cites this paper
• Effect of silkworm peptide on inducting M1 type polarization and Th1 activation via TLR2‐induced MyD88‐dependent pathway

  2019cites this paper
• Thymopentin ameliorates dextran sulfate sodium-induced colitis by triggering the production of IL-22 in both innate and adaptive lymphocytes

  2019cites this paper
• High yield expression, characterization, and biological activity of IFNα2-Tα1 fusion protein

  2019cites this paper
• Thymopentin promotes ovarian angiogenesis in mice by activating N6-methyladenosine (m6A) RNA modification of key factors in the Notch/Tie1 pathway

  2019cites this paper
• A Reappraisal of Thymosin Alpha1 in Cancer Therapy

  2019cites this paper
• Effect of a C-end rule modification on antitumor activity of thymosin α1.

  2018cites this paper
• Generation of a novel long-acting thymosin alpha1-Fc fusion protein and its efficacy for the inhibition of breast cancer in vivo.

  2018cites this paper
• Immune regulation effect of lienal polypeptides extract in Lewis lung carcinoma-bearing mice treated with cyclophosphamide

  2018cites this paper
• Protective Effect of Bergenin against Cyclophosphamide-Induced Immunosuppression by Immunomodulatory Effect and Antioxidation in Balb/c Mice

  2018cites this paper
• Sulfated polysaccharide of Sepiella Maindroni ink inhibits the migration, invasion and matrix metalloproteinase-2 expression through suppressing EGFR-mediated p38/MAPK and PI3K/Akt/mTOR signaling pathways in SKOV-3 cells.

  2018cites this paper
• Tetrahydro-β-carboline-3-carboxyl-thymopentin: a nano-conjugate for releasing pharmacophores to treat tumor and complications.

  2016cites this paper
• Targeting the replisome with transduced monoclonal antibodies triggers lethal DNA replication stress in cancer cells.

  2016cites this paper
• Effect of the herbal formulation Jianpijiedu on the TCRVβCDR3 repertoire in rats with hepatocellular carcinoma and subjected to food restriction combined with laxative

  2015cites this paper
• Increased antitumor activity of tumor-specific peptide modified thymopentin.

  2014cites this paper
• HSOA Journal of Cancer Biology and Treatment

  year unknowncites this paper